Clinical management patterns and treatment outcomes in patients with non-small cell lung cancer (NSCLC) across Europe: EPICLIN-Lung study
Carrato, A, Vergnenègre, A, Thomas, M, McBride, K, Medina, J, Cruciani, G
Published in Current medical research and opinion (01.03.2014)
Published in Current medical research and opinion (01.03.2014)
Get more information
Journal Article
Impact of chronic airflow obstruction in a working population
Roche, N, Dalmay, F, Perez, T, Kuntz, C, Vergnenegre, A, Neukirch, F, Giordanella, J-P, Huchon, G
Published in The European respiratory journal (01.06.2008)
Published in The European respiratory journal (01.06.2008)
Get full text
Journal Article
3029 POSTER Quality of Life (QoL) in Patients Receiving Treatment for Non-small Cell Lung Cancer (NSCLC) Across Europe: EPICLIN-Lung Study
Thomas, M, Cruciani, G, Vergnenègre, A, Blasco-Colmenares, E, Medina, J, Currato, A
Published in European journal of cancer (1990) (2011)
Published in European journal of cancer (1990) (2011)
Get full text
Journal Article
Multicenter observational study of erlotinib therapy (OBSTAR) for non small-cell lung cancer: A GFPC study
Vergnenègre, A, Monnet, I, Chouaïd, C, Hureaux, J, Mazières, J, Quéré, G, Lombard, J.N, Cumin, I, Abdiche, S, Ejnaini, C. Nocent, Bonnabau, H, Decroisette, Ch
Published in Lung cancer (Amsterdam, Netherlands) (01.11.2011)
Published in Lung cancer (Amsterdam, Netherlands) (01.11.2011)
Get full text
Journal Article
Chronic bronchitis among French adults: high prevalence and underdiagnosis
Huchon, G.J, Vergnenegre, A, Neukirch, F, Brami, G, Roche, N, Preux, P-M
Published in The European respiratory journal (01.10.2002)
Published in The European respiratory journal (01.10.2002)
Get full text
Journal Article
Update on the treatment of non-small-cell lung cancer: focus on the cost-effectiveness of new agents
Vergnenègre, A, Borget, I, Chouaid, C
Published in ClinicoEconomics and outcomes research (01.01.2013)
Published in ClinicoEconomics and outcomes research (01.01.2013)
Get full text
Journal Article
Economics of the clinical management of lung cancer in France: an analysis using a Markov model
CHOUAÏD, C, MOLINIER, L, COMBESCURE, C, DAURES, J. P, HOUSSET, B, VERGNENEGRE, A
Published in British journal of cancer (26.01.2004)
Published in British journal of cancer (26.01.2004)
Get full text
Journal Article
Multicentre phase II study of cisplatin–etoposide chemotherapy for advanced large-cell neuroendocrine lung carcinoma: the GFPC 0302 study
Le Treut, J., Sault, M.C., Lena, H., Souquet, P.J., Vergnenegre, A., Le Caer, H., Berard, H., Boffa, S., Monnet, I., Damotte, D., Chouaid, C.
Published in Annals of oncology (01.06.2013)
Published in Annals of oncology (01.06.2013)
Get full text
Journal Article
A phase II study of weekly cisplatine plus oral vinorelbine with concomittant radiotherapy in non-dependent elderly patients with localized inoperable non small cell lung carcinoma (Essai GFPC 08-06, Raccosa)
Locher, C, Pourel, N, Marin, B, Vergnenègre, A
Published in Revue des maladies respiratoires (01.01.2011)
Published in Revue des maladies respiratoires (01.01.2011)
Get more information
Journal Article
Airway obstruction and rheumatoid arthritis
Vergnenegre, A, Pugnere, N, Antonini, MT, Arnaud, M, Melloni, B, Treves, R, Bonnaud, F
Published in The European respiratory journal (01.05.1997)
Published in The European respiratory journal (01.05.1997)
Get full text
Journal Article
PCN126 OVERVIEW OF PRIMARY ENDPOINTS, PROGRESSION-FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) FOR NON-SMALL CELL LUNG CANCER (NSCLC): THEIR VALUE IN TREATMENT DECISIONS AND PATIENT CARE
Heron, L, De Castro Carpeño, J, Chouaid, C, Vergnenègre, A, Bischoff, H.G, Walzer, S
Published in Value in health (2011)
Published in Value in health (2011)
Get full text
Journal Article
P69 Study ESOGIA-GFPC 08–02 – elderly selection on geriatric index assessment
Corre, R, Vergnenègre, A, Le Caer, H, Fournel, P
Published in Critical reviews in oncology/hematology (2009)
Published in Critical reviews in oncology/hematology (2009)
Get full text
Journal Article
Economic impact of second- and third-line erlotinib treatment of non small-cell lung cancer
Chouaid, C, Moser, A, Coudray-Omnès, C, Vergnenègre, A
Published in Revue des maladies respiratoires (01.11.2008)
Published in Revue des maladies respiratoires (01.11.2008)
Get more information
Journal Article
Phase II randomized multicenter study evaluating a treatment regimen alternating docetaxel and cisplatin–vinorelbine with a cisplatin–vinorelbine control group in patients with stage IV non-small-cell lung cancer: GFPC 97.01 study
Pérol, M., Léna, H., Thomas, P., Robinet, G., Fournel, P., Coste, E, Belleguic, C., Le Caer, H., Blanchon, F., Vergnenègre, A., Vernejoux, J.-M, Schuller-Lebeau, M.-P., Pham, E.
Published in Annals of oncology (01.05.2002)
Published in Annals of oncology (01.05.2002)
Get full text
Journal Article
Docetaxel and concurrent radiotherapy after two cycles of induction chemotherapy with cisplatin and vinorelbine in patients with locally advanced non-small-cell lung cancer : A phase II trial conducted by the Groupe Français de Pneumo-Cancérologie (GFPC)
VERGNENEGRE, A, DANIEL, C, PREUX, P. M, ROBINET, G, LENA, H, FOURNEL, P, KLEISBAUER, J. P, LE CAER, H, LETREUT, J, PAILLOTIN, D, PEROL, M, BOUCHAERT, E
Published in Lung cancer (Amsterdam, Netherlands) (01.03.2005)
Published in Lung cancer (Amsterdam, Netherlands) (01.03.2005)
Get full text
Journal Article